GeneDx selloff after short report ‘appears overdone,’ says Wells Fargo
Wells Fargo notes that shares of GeneDx (WGS) are trading lower after a short report was published this morning by Grizzly Research, adding ...
GeneDx drops after short report; Wall Street analysts defend (update)
Adds analyst comment. GeneDX (NASDAQ:WGS) fell 4% after a short report from Grizzly Research on the genetic testing company. Grizzly Research disclosed that it's short shares of GeneDX (NASDAQ:WGS).
BTIG maintains GeneDx stock Buy rating, $95 target amid fraud claim
BTIG analysts stood firm on their positive stance towards GeneDx (NASDAQ:WGS), reiterating a Buy rating and a $95.00 price target for the company's stock. With analyst targets ranging from $70 to $118 ...
TD Cowen Reaffirms Their Buy Rating on GeneDx Holdings (WGS)
TD Cowen analyst Daniel Brennan maintained a Buy rating on GeneDx Holdings (WGS – Research Report) today and set a price target of $118.00. The ...